Home/Filings/4/0001213900-26-006709
4//SEC Filing

Fabbio Patrick 4

Accession 0001213900-26-006709

CIK 0001359931other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 4:30 PM ET

Size

5.1 KB

Accession

0001213900-26-006709

Research Summary

AI-generated summary of this filing

Updated

Protara (TARA) CFO Patrick Fabbio Sells 3,063 Shares

What Happened Patrick Fabbio, Chief Financial Officer of Protara Therapeutics (TARA), had 3,063 shares disposed (withheld) to satisfy tax withholding related to vested restricted stock units. The shares were disposed at $5.60 per share, for a total value of $17,153. This was a tax-withholding disposition (routine) rather than a market sale indicating investment sentiment.

Key Details

  • Transaction date: 2026-01-20; Price: $5.60 per share; Shares disposed: 3,063; Total value: $17,153.
  • Transaction code: F (shares withheld to satisfy tax withholding obligations).
  • Footnote: F1 — Shares were withheld by the issuer to satisfy income tax obligations associated with the vesting of an RSU award granted to the reporting person on January 19, 2024.
  • Shares owned after the transaction: not specified in the filing.
  • Filing timing: Form 4 was filed 2026-01-22 for the 2026-01-20 transaction; no late filing indication in the record.

Context This transaction reflects tax withholding on RSU vesting (a routine administrative disposition) rather than a discretionary open-market sale or purchase. Such withholdings are common when equity awards vest and do not necessarily indicate the insider’s view on the company’s prospects.

Insider Transaction Report

Form 4
Period: 2026-01-20
Fabbio Patrick
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-01-20$5.60/sh3,063$17,15367,376 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024.
Signature
/s/ Patrick Fabbio|2026-01-22

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1
  • filerCIK 0001658859

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:30 PM ET
Size
5.1 KB